))
A Conversation with Travera
Manage episode 371302390 series 3237644
Content provided by Down There Aware. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Down There Aware or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
This week Mary and Alex speak with Cliff Reed, Founding CEO, and Dennis Watson, VP Business Development, of Travera, a company specializing in new technology enhancing the landscape of late stage cancer treatment.
Listen on our website, www.downthereaware.com/podcast, or wherever you get your podcasts.
#Podcast #Spotify #Anchor #research #advocacy #cancer #Travera #genomics #DNA #MIT #FDA #CLIA #LDT #cancerresearch #technology #cancertechnology #innovation #groundbreaking #latestagecancer #stage4cancer #uterinecancer #ovariancancer #leukemia
Stay Connected
Email Us: downthereaware@gmail.com
Instagram:@downthereaware
Facebook: Down There Aware
Twitter: @downthereaware
Pinterest: Down There Aware
TikTok: Down There Aware
Episode Links
Episode Highlights
Intro [0:13]
Welcome Back! [1:25]
Guest introductions [1:44]
M.I.T. technology [3:42]
Genomics and DNA sequencing [3:58]
Limited patients [4:05]
New measurement tool [4:48]
MIT/Dana Farber Cancer Institute partnership [5:32]
Infectious disease comparison [5:48]
Multiple Myeloma [6:38]
“Cheat code” [7:30]
Commercial launch [9:09]
Test offered for free [10:15]
Working with physicians [10:55]
Trial and error process for patient [13:20]
Advocacy groups [15:25]
Patient profile [16:01]
Cancer mutation [17:57]
Access to live cancer cells [18:38]
Quick turn-around for results[21:30]
No additional burden on patient [23:35]
Early stage testing and limited data [24:28]
Predictive accuracy over 80% [25:12]
Late stage cancer patients [26:25]
Response from oncology community [28:00]
Difference in this x vivo test [29:25}
No financial risk [30:00]
Great value to research and future patients [31:57]
MIT intent [34:57]
Great creative minds in scientific research [36:15]
Future of Travera’s efforts [36:55]
The bigger plan [39:01]
FDA approval/CLIA certification [40:05]
Laboratory Developed Test (LDT) [40:21]
Potential to greatly benefit newly diagnosed patients[41:49]
Microchip specs [43:45]
Physics vs biochemistry[46:20]
Simple comparison to a diving board [47:05]
Speed and logic [49:47]
If someone is listening today and is interested [51:30]
dwatson@travera.com [52:23]
PHI and HIPAA [53:35]
Hearing from those who know best [55:03]
Thanks for listening! [56:19]
Stay Connected
Podcast, Spotify, Anchor, research, advocacy, cancer, Travera, genomics, DNA, MIT, FDA, CLIA, LDT, cancer research, technology, cancer technology, innovation, groundbreaking, late-stage cancer, stage 4 cancer, uterine cancer, ovarian cancer, leukemia
127 episodes
Share
